Cargando…

Five-year follow-up study of a population-based prospective cohort of men with low-risk prostate cancer: the treatment options in prostate cancer study (TOPCS): study protocol

INTRODUCTION: Active surveillance (AS) is recommended for men with low-risk prostate cancer (LRPC) to reduce overtreatment and to maintain patients’ quality of life (QOL). However, whether African American (AA) men can safely undergo AS is controversial due to concerns of more aggressive disease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinping, Goodman, Michael, Janisse, James, Cher, Michael L, Bock, Cathryn Hufford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860062/ https://www.ncbi.nlm.nih.gov/pubmed/35190441 http://dx.doi.org/10.1136/bmjopen-2021-056675

Ejemplares similares

Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study
por: Chambers, Suzanne K, et al.
Publicado: (2018)

Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer
por: Smith, Allan Ben, et al.
Publicado: (2017)

Discussion of Treatment Options for Metastatic Hormone Sensitive Prostate Cancer Patients
por: Sigurdson, Samantha S., et al.
Publicado: (2020)

Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer
por: Basourakos, Spyridon P., et al.
Publicado: (2021)

Salvage Reirradiation Options for Locally Recurrent Prostate Cancer: A Systematic Review
por: Zhong, Jim, et al.
Publicado: (2021)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy
por: Graff, Julie N., et al.
Publicado: (2020)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer
por: Emery, Jon, et al.
Publicado: (2014)

Evaluation of Polygenic Risk Scores for Prediction of Prostate Cancer in Korean Men
por: Oh, Jong Jin, et al.
Publicado: (2020)

Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent
por: Johnson, Jabril R., et al.
Publicado: (2021)

Racial Disparity in Prostate Cancer-Specific Mortality for High-Risk Prostate Cancer: A Population-Based Study
por: Wang, Chenyang, et al.
Publicado: (2017)

Immune Infiltration and Prostate Cancer
por: Strasner, Amy, et al.
Publicado: (2015)

MRI Radiomics in Prostate Cancer: A Reliability Study
por: Urraro, Fabrizio, et al.
Publicado: (2021)

(125)Iodine monotherapy for Japanese men with low- and intermediate-risk prostate cancer: outcomes after 5 years of follow-up
por: Sekiguchi, Akane, et al.
Publicado: (2014)

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

The Effect of 10 Most Common Nonurological Primary Cancers on Survival in Men With Secondary Prostate Cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer
por: Nguyen, Carvell T., et al.
Publicado: (2012)

Tumor-Specific Induction of the Intrinsic Apoptotic Pathway—A New Therapeutic Option for Advanced Prostate Cancer?
por: Wolf, Philipp
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15)
por: Aghdam, Nima, et al.
Publicado: (2020)

Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)
por: Pepin, Abigail, et al.
Publicado: (2020)

Real-World Treatment Patterns in Men with Castration- Resistant Prostate Cancer Receiving Docetaxel
por: Davis, Keith L., et al.
Publicado: (2015)

A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy
por: Lim Joon, Daryl, et al.
Publicado: (2023)

Bone Complications Among Prostate Cancer Survivors: Long-Term Follow-Up From the Prostate Cancer Outcomes Study
por: Morgans, Alicia K., et al.
Publicado: (2014)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Testing
por: Kappen, Sanny, et al.
Publicado: (2021)

Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies
por: Kendrick, Jake, et al.
Publicado: (2021)

New Diagnostic Model for Clinically Significant Prostate Cancer in Biopsy-Naïve Men With PIRADS 3
por: Huang, Chen, et al.
Publicado: (2022)

A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer
por: Hasannejadasl, Hajar, et al.
Publicado: (2023)

Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
por: Frank, Sander B., et al.
Publicado: (2013)

Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
por: Che, Bangwei, et al.
Publicado: (2021)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Community pharmacy lifestyle intervention to increase physical activity and improve cardiovascular health of men with prostate cancer: a phase II feasibility study
por: Lemanska, Agnieszka, et al.
Publicado: (2019)

Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer
por: Zhou, Yongheng, et al.
Publicado: (2022)

Molecular Targets for Radiation Oncology in Prostate Cancer
por: Wang, Tao, et al.
Publicado: (2011)

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection
por: Chiu, Shih-Ting, et al.
Publicado: (2021)

The Metabolic Phenotype of Prostate Cancer
por: Eidelman, Eric, et al.
Publicado: (2017)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_held79ft0da1rkdhdck8ui9s09